Related Experiment Video
Updated: Sep 29, 2025

07:46
CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
6.0K
Approaches for CRISPR/Cas9 Genome Editing in C. elegans.
Charlotte J Martin1, John A Calarco2
1Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
Methods in Molecular Biology (Clifton, N.J.)
|March 23, 2022
Summary
We present updated protocols for using the clustered regularly interspaced short palindromic repeat (CRISPR)-associated Cas9 system in C. elegans. This method offers an effective way to make heritable changes to the worm genome.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- The clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) nuclease Cas9 is a powerful tool for genome editing.
- Cas9 has been widely adopted across various organisms for precise genetic modifications.
- Efficient genome engineering in the model organism C. elegans is crucial for biological research.
Purpose of the Study:
- To describe updated protocols for utilizing the Streptococcus pyogenes Cas9 system in Caenorhabditis elegans.
- To provide a convenient and effective method for generating heritable genomic alterations in C. elegans.
- To outline considerations for selecting optimal genome editing strategies in C. elegans.
Main Methods:
- Utilizing the S. pyogenes Cas9 nuclease for targeted genome modification.
- Implementing established and refined protocols for CRISPR-Cas9 applications in C. elegans.
- Evaluating different strategies for achieving specific mutations and transgene insertions.
Main Results:
- Demonstration of a convenient and effective approach for heritable genome modification in C. elegans.
- Successful generation of specific mutations and transgene insertions using the CRISPR-Cas9 system.
- Presentation of key considerations to guide experimental design for C. elegans genome editing.
Conclusions:
- The updated CRISPR-Cas9 protocols offer a robust method for genetic manipulation in C. elegans.
- These protocols facilitate efficient and heritable genomic changes, advancing research in this model organism.
- Careful consideration of experimental needs ensures the successful application of CRISPR-Cas9 strategies in C. elegans.
Related Concept Videos
CRISPR/Cas9 Genome Editing
511
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
511
CRISPR
53.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.2K
CRISPR and crRNAs
17.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.6K

